'Dodgy dossier' partly to blame for failure of war against malaria in the tropicsSeptember 11, 2008The war against malaria in tropical countries was fought and lost in the 20th Century on the basis of faulty intelligence, a 'dodgy dossier' which argued that the same methods used to tackle the disease in temperate countries would also work in the tropics. Eradication failed in almost every tropical and sub-tropical country, because tactics that had been proven to work in countries such as the USA, Greece and Italy were also deployed in tropical countries, despite the existence of evidence that they would they not work, particularly in sub-Saharan Africa. Dr. Colin Sutherland, a Senior Lecturer at the London School of Hygiene & Tropical Medicine, who is contributing to a session entitled 'How science addresses developing world issues' at the BA Festival of Science in Liverpool today, explains: 'Previous efforts to eradicate malaria, if considered on a nation-by-nation basis, only succeeded in countries where the Plasmodium parasite was weak and its mosquito vector was vulnerable, particularly where populations were wealthy enough to afford the best tools available. 'The failure to eradicate malaria in tropical countries, where the parasite is now at its strongest, and the mosquitoes are doing very well, thank you very much is, in part, due to the miscalculation that a one-size-fits-all approach would be effective in every setting - a miscalculation that could have been avoided if we had heeded the evidence from Africa over half a century ago', he adds. Dr. Sutherland cautions against the obsession among the western media with the 'scientific breakthrough', a concept which consequently dominates popular notions of science. Although breakthroughs do occur, and are undoubtedly newsworthy when they do, it is the careful synthesis of incremental advances in knowledge, and the dissemination of that knowledge to key decision-makers, health ministries and governments that will help us win the war against malaria. Today's session will look at ways of best achieving this, with a particular focus on open access publishing. It will also emphasise the importance of training and support for high calibre African scientists. 'In the war against malaria, knowledge is the most powerful weapon we have', concludes Dr. Sutherland. London School of Hygiene & Tropical Medicine |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||